About Universitätsklinikum Leipzig Medizinische Klinik II Gastroenterolog. u. Hepatolog.
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Universitätsklinikum Leipzig Medizinische Klinik II Gastroenterolog. u. Hepatolog.
During the past decade, Universitätsklinikum Leipzig Medizinische Klinik II Gastroenterolog. u. Hepatolog. conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on
average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients
Hemodynamic Resuscitation and Monitoring in Early Sepsis
2019-10-22
2023-01-31
Active, not recruiting
500
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Leipzig Medizinische Klinik II Gastroenterolog. u. Hepatolog."
#1 collaborator was "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Universitätsklinikum Leipzig Medizinische Klinik II Gastroenterolog. u. Hepatolog.
According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Leipzig Medizinische Klinik II Gastroenterolog. u. Hepatolog." are
"Multiple Myeloma" (2 trials), "B-cell Lymphoma" (1 trials), "Carcinoma, Hepatocellular" (1 trials), "Myelodysplastic Syndromes" (1 trials) and "Newly Diagnosed Multiple Myeloma" (1 trials). Many other conditions were trialed in "Universitätsklinikum Leipzig Medizinische Klinik II Gastroenterolog. u. Hepatolog." in a lesser frequency.
Clinical Trials Intervention Types at Universitätsklinikum Leipzig Medizinische Klinik II Gastroenterolog. u. Hepatolog.
Most popular intervention types in "Universitätsklinikum Leipzig Medizinische Klinik II Gastroenterolog. u. Hepatolog." are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (2 trials), "Placebo" (2 trials), "Aspirin" (1 trials), "Atezolizumab" (1 trials) and "CC-5013" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Universitätsklinikum Leipzig Medizinische Klinik II Gastroenterolog. u. Hepatolog.
The vast majority of trials in "Universitätsklinikum Leipzig Medizinische Klinik II Gastroenterolog. u. Hepatolog." are
6 trials for "All" genders.
Clinical Trials Status at Universitätsklinikum Leipzig Medizinische Klinik II Gastroenterolog. u. Hepatolog.
Currently, there are NaN active trials in "Universitätsklinikum Leipzig Medizinische Klinik II Gastroenterolog. u. Hepatolog.".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Universitätsklinikum Leipzig Medizinische Klinik II Gastroenterolog. u. Hepatolog.,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Universitätsklinikum Leipzig Medizinische Klinik II Gastroenterolog. u. Hepatolog., 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".